Product Wiki · Recalls · Health Canada — Medical Devices

Ceftazidime 256 M.I.C.E — recall 56020

Health Canada — Medical Devices · Canada · 2016-08-22 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →

Agency: Health Canada — Medical Devices
Recall identifier: 56020
Date of alert: 2016-08-22
Country / jurisdiction: Canada
Risk level: Type II
Risk type: recall
Product category: Medical devices
Product type: Medical devices
Notice status: Archived by the issuing authority — kept for reference

Reported risk: A technical investigation has confirmed that CT1629B CAZ10, Ceftazidime batch 1426486 may contain discs with a reduced concentration of antibiotic that may impact performance testing with Pseudomonas aeruginosa ATCC 27853 (European Committee on Antimicrobial Susceptibility Testing (EUCAST) Quality Performance). Continued used of this lot could result in quality control failures, delayed results or incorrect results reporting (false resistance).

Primary source: https://recalls-rappels.canada.ca/en/alert-recall/ceftazidime-256-mice

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Ceftazidime 256 M.I.C.E — recall 56020

Related